Company: INTS
Filing Date: 2025-04-24
Form Type: S-1/A
Source: 0001628280-25-019491
Chunk: 71

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-24
Form: S-1/A
Chunk 71
---
 for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

<div align='center'>II-6</div>

### SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Registration Statement to be signed on its behalf by the undersigned hereunto duly authorized, on this 24th day of April, 2025.

| INTENSITY THERAPEUTICS, INC. |     |                                       |
| By:                          |     | /s/ Lewis H. Bender                   |
|                              |     | Lewis H. Bender                       |
|                              |     | President and Chief Executive Officer |

<div align='center'>II-7</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.

| Name                     
 /s/ Lewis H. Bender      |     | Title                                           
 President, Chief Executive Officer and Chairman |     | Date |     | April 24, 2025 |
|:-------------------------|:----|:------------------------------------------------|:----|:-----|:----|:---------------|
| Lewis H. Bender          |     | -principal executive officer                    |     |      |     |                |
| /s/ Joseph Talamo        |     | Chief Financial Officer                         |     |      |     | April 24, 2025 |
| Joseph Talamo            |     | -principal financial officer                    |     |      |     |                |
| /s/ John Wesolowski      |     | Principal Accounting Officer and Controller     |     |      |     | April 24, 2025 |
| John Wesolowski          |     | -principal accounting officer                   |     |      |     |                |
| *                        |     | Director                                        |     |      |     | April